Company: KROS
Filing Date: 2025-06-09
Form Type: 8-K
Source: 0001664710-25-000057
Chunk: 1

Company: Keros Therapeutics, Inc.
Filing Date: 2025-06-09
Form: 8-K
Item: Item 5.07
Chunk 1
---
   Votes For      Votes Against      Votes Abstain  
 ────────────────────────────────────────────────────
  26,436,418            217,655            855,774  

There were no broker non-votes with respect to Proposal 2.

Proposal 3 - Advisory Vote on Executive Compensation

The Company’s stockholders approved, on a non-binding advisory basis, Proposal 3. The votes cast were as follows:

   Votes For      Votes Against      Votes Abstain      Broker Non-Votes  
 ──────────────────────────────────────────────────────────────────────────
  18,580,618          4,166,083            963,571             4,297,008  

Item 8.01 Other Events.